Revumenib - Syndax Pharmaceuticals
At a glance
- Drug Originator Vitae Pharmaceuticals
- Drug Licenced by Syndax Pharmaceuticals
- Drug Class Antineoplastics; Aza compounds; Benzamides; Cyclohexanes; Pyrimidines; Small molecules; Spiro compounds; Sulfonamides
- Mechanism of Action KMT2A protein inhibitors; Menin inhibitors; Protein-protein interaction inhibitors
- USA Patent Applicants SYNDAX
- USA Patents 2
- NDAs 1
- International Patents 35
- Patent Applications 6
Disclaimer